Duchenne muscular dystrophy

New York, June 22, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) accelerated approval of ELEVIDYS (delandistrogene…

FDA grants orphan drug designation for MetrioPharm’s lead compound MP1032 for the treatment of Duchenne muscular dystrophy (DMD)DMD is a designated orphan disease in both Europe and the…

Clinical studies to date "do not provide unambiguous evidence" for SRP-9001…

<!-- Name:DistributionId Value:8786626 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announces a $650,000 investment in Myosana Therapeutics via its MDA Venture Philanthropy (MVP)…

By IANS MUMBAI: Vishal Jethwa, who plays a terminally ill boy in the upcoming Kajol-starrer 'Salaam Venky', watched videos of people living with DMD (Duchenne…

Continued advancement of pamrevlumab clinical trials – topline data from five pivotal Phase 3 trials beginning in 1H 2023 through mid-2024Completed enrollment of MATTERHORN Phase 3 study of…

SAN FRANCISCO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the…

New York, USA, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Duchenne Muscular Dystrophy (DMD) Clinical Trial Analysis Featuring 60+ Companies | DelveInsight Duchenne Muscular Dystrophy pipeline…

"Corticosteroids are likely to remain the main treatment for DMD for the foreseeable future and worldwide so it is critical that we establish a standard of care that is backed by…